Christine M. Lovly
Vanderbilt University Medical Center
97 papers found
Refreshing results…
Managing Resistance to EFGR- and ALK-Targeted Therapies
Download from doi.orgCracking the Code of Resistance across Multiple Lines of ALK Inhibitor Therapy in Lung Cancer
Download from aacrjournals.orgTargeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade.
Download from aacrjournals.orgMajor milestones in translational oncology
Download from link.springer.comHeterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors
Download from aacrjournals.orgEGFR fusions as novel therapeutic targets in lung cancer
Download from aacrjournals.orgGuiding Oncology Patients Through the Maze of Precision Medicine
Download from www.researchgate.netMelanoma driver mutations and immune therapy
Download from europepmc.orgEPHA2 Blockade Overcomes Acquired Resistance to EGFR Kinase Inhibitors in Lung Cancer
Download from aacrjournals.orgTumor Heterogeneity and Therapeutic Resistance
Download from doi.orgRAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK–positive lung cancer
Download from www.nature.comLiquid biopsies reveal the dynamic nature of resistance mechanisms in solid tumors
Download from www.nature.comShades of T790M: Intratumor Heterogeneity in EGFR-Mutant Lung Cancer
Download from aacrjournals.orgMissing publications? Search for publications with a matching author name.